# Oseltamivir Phosphate with at Least a 10-year Shelf Life

Canonical: https://abierto.us/opportunities/75a50325f80003

- Solicitation number: 75A50325F80003
- Notice type: Award notice
- Status: Awarded to Genentech Usa, Inc. for $396,999,400.00
- Department: Department of Health and Human Services
- Agency: Office of Assistant Secretary for Preparedness and Response
- Contracting office: Aspr/Orm-Sns (75A503)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- Place of performance: South San Francisco, California
- County: San Mateo County (FIPS 06081). https://abierto.us/counties/san-mateo-county-ca-06081
- City: South San Francisco. https://abierto.us/cities/south-san-francisco-ca-0673262
- First posted: January 31, 2025
- Last posted: January 31, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/b9fc235784424fe69f9b178abcb43916/view

## Description

Delivery order 75A50325F80003 was awarded under the authority of a Limited Source Justification pursuant to FAR 8.405-6(a)(1)(i)(B), only one source is capable of providing the supplies required at the level or quality required because the supplies or services are unique or highly specialized for the supply of oseltamivir phosphate with at least a 10-year shelf life. The NAICS code for this procurement is 325412, Pharmaceutical and Preparation Manufacturing.

Period of performance – from date of award for 24 months thereafter. The Administration for Strategic Preparedness and Response, Center for the Strategic National Stockpile (SNS) awarded a firm fixed-price delivery order to Genentech USA, Inc., located at 1 DNA Way, South San Francisco, CA 94080-4918. This delivery order was awarded to replace expiring Tamiflu (oseltamivir phosphate) 30mg and 75mg capsules with long shelf-life oseltamivir phosphate 30mg and 75mg capsules with at least a 10-year shelf-life.

Replacement ensures that the SNS maintains its stockpile of Influenza antivirals that have long-term stability and potency, and that remain deployable and available for an emergency without any additional procurement or government-funded drug stability studies. Oseltamivir phosphate is an antiviral medication primarily used to treat acute Influenza A and B in patients experiencing symptoms for less than 48 hours.

Oseltamivir phosphate works by inhibiting a key enzyme necessary for viral replication, reducing the severity and duration of flu symptoms, facilitating faster recovery, and offering preventative benefits when exposure to the virus occurs.

## Award on USAspending

- Recipient: Genentech Usa, Inc. (UEI SA85BMHCTXK5)
- Contract: 75A50325F80003 under 36F79723D0219, delivery order
- Obligated: $45,106,864.00
- Competition: Full and Open Competition, 1 offers received
- Link: solicitation number 75A50325F80003 was reused as the contract number; same awarding office 75A503 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75A50325F80003_7505_36F79723D0219_3600/

- Recipient: Genentech Usa, Inc. (UEI SA85BMHCTXK5)
- Contract: 36F79723D0219
- Obligated: $0.00
- Competition: Full and Open Competition, 999 offers received
- Link: award number 36F79723D0219 equals the contract number; awarding office not confirmed (medium confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_36F79723D0219_3600/


## Publications

- January 31, 2025: Award notice. Notice b9fc235784424fe69f9b178abcb43916. https://sam.gov/workspace/contract/opp/b9fc235784424fe69f9b178abcb43916/view

## Points of contact

- Terri Reed, terri.reed@hhs.gov
- Kimberly Golden, kimberly.golden1@hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75a50325f80003.